Clinical Trial Update: An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer [Phase 2]

View source ↗

Summary

An exploratory Phase 2 clinical trial evaluating HRS-4642 in combination with immunotherapy and chemotherapy for pancreatic cancer, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HRS-4642

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING